Medical biotechnology and Immunology
05-May-2021
Corona pandemic is a complex problem and needs transdisciplinary studies in various branches of Biotechnology.
The development of Medical biotechnology and Immunology to produce pharmaceutical and diagnostic products is playing significant contributions in medical science. It is a matter of current discussion in immunologists about the rationale and clinical outcome of therapeutic strategies and prospective clinical trials to prevent or treat the covid infection. It is to be hoped that the lessons we learned, help us to prevent possible pandemic in the near future.
๐
๐จ๐ซ ๐ฆ๐จ๐ซ๐ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง, ๐๐๐๐ฅ ๐๐ซ๐๐ ๐ญ๐จ ๐๐ข๐ฌ๐๐ฎ๐ฌ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐จ๐ฎ๐ซ ๐๐ฑ๐ฉ๐๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐๐๐ข๐๐๐ฅ ๐๐ข๐จ๐ญ๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ง๐ ๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ฅ๐จ๐ ๐ฒ, ๐๐ซ ๐๐๐ง๐๐๐๐ฉ ๐. ๐๐๐๐๐๐๐๐๐๐๐, PhD, Post Doc. from Pasteur Institute, France, Senior Scientist & Founder Head Centre for Innovation, Research & Development โ CIRD Dr. B. Lal Clinical Laboratory Pvt Ltd.
Or, Call: 9829 038 377